| GANX Stock | | | USD 1.86 0.12 6.90% |
Gain Therapeutics financial indicator trend analysis is much more than just examining Gain Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gain Therapeutics is a good investment. Please check the relationship between Gain Therapeutics Total Current Liabilities and its Property Plant And Equipment Net accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Gain Stock please use our
How to Invest in Gain Therapeutics guide.
Total Current Liabilities vs Property Plant And Equipment Net
Total Current Liabilities vs Property Plant And Equipment Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Gain Therapeutics Total Current Liabilities account and
Property Plant And Equipment Net. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Gain Therapeutics' Total Current Liabilities and Property Plant And Equipment Net is 0.81. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Gain Therapeutics, assuming nothing else is changed. The correlation between historical values of Gain Therapeutics' Total Current Liabilities and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Gain Therapeutics are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Total Current Liabilities i.e., Gain Therapeutics' Total Current Liabilities and Property Plant And Equipment Net go up and down completely randomly.
Correlation Coefficient | 0.81 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Total Current Liabilities
Total Current Liabilities is an item on Gain Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Gain Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Gain Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gain Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Gain Stock please use our
How to Invest in Gain Therapeutics guide.At this time, Gain Therapeutics'
Tax Provision is fairly stable compared to the past year.
Selling General Administrative is likely to rise to about 11.3
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 3
M in 2024.
Gain Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Gain Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gain Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to
measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.